Pitney Bowes (PBI) just packed several investor-relevant updates into its latest quarterly release, combining third quarter earnings, a refreshed full year revenue outlook, and a reaffirmed dividend.
Recent trading has cooled after a strong run, with the share price down 5.5% over the last month and 10.2% over 90 days. Yet Pitney Bowes still carries a 51.5% year to date share price return and a 1 year total shareholder return of 72.1%, which signals momentum built over a longer stretch.
Scan beyond Pitney Bowes and evaluate other companies with similar momentum and fundamentals using our hand picked list of 21 high quality undiscovered gems.
After that strong year to date run and a recent pullback, Pitney Bowes now trades at a price that sits well below both analyst targets and intrinsic estimates. How far does that gap stretch on a fair value view?
On the most followed narrative, Pitney Bowes screens on a fair value of $17.30 against a last close of $15.65. This leaves the share price sitting below that modeled outcome and puts the focus squarely on whether the business can earn its way into that gap under current revenue assumptions.
The main thing that has to go right is that Pitney Bowes executes on its shift toward higher margin SendTech and Presort offerings, while continuing to de risk the balance sheet and improve earnings and free cash flow within its current revenue outlook.
The current numbers and guidance imply that Pitney Bowes stock already reflects a fair outcome, with the share price incorporating disciplined execution on margins, debt reduction, and capital efficiency rather than a strong recovery in revenue.
See why 0 investors see Pitney Bowes as 10% undervalued.
Result: Fair Value of $17.30 (UNDERVALUED)
Still, there are clear swing factors, including whether Presort can absorb new volumes efficiently and whether SendTech products like SendPro CX can slow the revenue drag in mailing.
Find out about the key risks to this Pitney Bowes narrative.
Mixed signals around Pitney Bowes can be confusing, so move quickly, review the underlying figures for yourself, and weigh the 5 key rewards and 2 important warning signs.
If you only stop at Pitney Bowes, you may miss out on companies with stronger balance sheets, different risk levels, or more attractive valuations uncovered by systematic screening.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com